Back to All Resources

Non-Clinical Safety Considerations when Developing Targeted Protein Degraders

May 10, 2022

Applied Pharmaceutical Toxicology (APT) 2022

Screen Shot 2022-05-12 at 7.38.18 AM
View Presentation
Area of Focus
Targeted Protein Degradation
Programs
Other
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link

You may also be interested in these resources

August 15, 2022
MQAtlas Creates a Deep, Accurate and Global E3 Expression Atlas Enabling Targeted Protein Degradation Based Precision Medicine
The 14th International Symposium on Mass Spectrometry in the Health and Life Sciences
View Resource
December 7, 2022
Proteomics enabling TPD Drug Discovery
TPD Assay Development and Screening Summit
View Resource